Published in Blood Weekly, March 6th, 1995
The vaccine is indicated for active immunization in people at risk of exposure to hepatitis A virus, including travelers to Mexico, parts of the Caribbean, South and Central America, Africa, Asia (except Japan), the Mediterranean basin, Eastern Europe and the Middle East. Havrix, manufactured by SmithKline Beecham Biologicals and distributed by SmithKline Beecham Pharmaceuticals, provides protection against hepatitis A.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.